Ftse Mib
37.722,63
-3,45%
DAX
22.326,81
-3,51%
S&P 500
5.778,15
-1,22%
NASDAQ
18.285,16
-0,35%
Bitcoin
87.912,99
2,12%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ ABVC BioPharma Inc (ABVC) ABVC BioPharma Inc (ABVC) Notizie

ABVC BioPharma Inc

ABVC
0,6641
-0,0261 (-3,78%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 22:30:44
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/2/202523:13EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
06/1/202523:00EDGAR2Form 8-K - Current report
19/12/202414:30GLOBEABVC BioPharma Seeks to Revolutionize Mental Health..
11/12/202412:30GLOBEABVC BioPharma Secures $200,000 in First Cash Licensing..
15/11/202421:31EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
15/11/202421:30EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
15/11/202421:28EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
15/11/202421:26EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
15/11/202401:33EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202415:25EDGAR2Form 8-K - Current report
14/11/202415:00GLOBEABVC BioPharma, Inc. Reports Q3 2024 Financial Results and..
14/11/202414:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/11/202423:00EDGAR2Form 8-K - Current report
25/10/202418:21EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
22/10/202414:45GLOBEABVC BioPharma Receives $50,000 in Incremental Licensing..
18/10/202423:23EDGAR2Form 8-K - Current report
10/9/202422:01EDGAR2Form 8-K - Current report
20/8/202422:30EDGAR2Form 8-K - Current report
16/8/202422:31EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
16/8/202422:30EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
15/8/202413:30GLOBEABVC BioPharma, Inc. Reports Strong Q2 2024 Financial..
15/8/202413:00EDGAR2Form 8-K - Current report
14/8/202421:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202423:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
02/8/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
26/7/202422:30EDGAR2Form POS AM - Post-Effective amendments for registration..
23/7/202423:00EDGAR2Form 8-K - Current report
12/7/202422:05EDGAR2Form 8-K - Current report
12/7/202422:00EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
24/5/202414:00EDGAR2Form 8-K - Current report
23/5/202423:00EDGAR2Form 8-K - Current report
23/5/202422:30EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
22/5/202423:00EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
22/5/202420:31EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
17/5/202423:00EDGAR2Form 8-K/A - Current report: [Amend]
17/5/202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/5/202423:00EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
15/5/202415:00EDGAR2Form 8-K - Current report
09/5/202415:27EDGAR2Form 8-K - Current report
18/4/202415:25GLOBEAiBtl BioPharma Inc. Acquired TT Life Company, Valued at..
17/4/202415:00GLOBEABVC BioPharma Executes a Global Licensing Definitive..
10/4/202414:30GLOBEABVC BioPharma Executes a Global Licensing Term Sheet for..
26/3/202413:30GLOBEABVC BioPharma Entered into a Global Licensing Deal of..
21/3/202413:30GLOBEAiBtl BioPharma Inc. Completes $7.6M Land Deal: Exchanging..
19/3/202413:30GLOBEABVC BioPharma, Inc. CEO Selected as 2024 Top 10 CEO in CEO..
14/3/202414:30GLOBEABVC BioPharma Reports Annual 2023 Financials and Provides..
Apertura: 0,6902 Min: 0,632 Max: 0,7196
Chiusura: 0,6902

La tua Cronologia

NASDAQ
ABVC
ABVC BioPharma
BIT
P1SXO6
BNP Paribas Issuance
BOV
H1PE34
Hewlett Packard Enterprise
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci